Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2006 1
2008 2
2009 2
2010 4
2011 3
2012 4
2013 11
2014 8
2015 13
2016 15
2017 16
2018 11
2019 10
2020 7
2021 5
2022 14
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
Immune Effects of Intra-Arterial Liver-Directed Therapies.
Karimi A, Yarmohammadi H, Erinjeri JP. Karimi A, et al. Among authors: erinjeri jp. J Vasc Interv Radiol. 2024 Feb;35(2):178-184. doi: 10.1016/j.jvir.2023.10.019. J Vasc Interv Radiol. 2024. PMID: 38272638 Review.
Three-Dimensional Margin as a Predictor of Local Tumor Progression after Microwave Ablation: Intraprocedural versus 4-8-Week Postablation Assessment.
Zirakchian Zadeh M, Sotirchos VS, Kirov A, Lafontaine D, Gönen M, Yeh R, Kunin H, Petre EN, Kitsel Y, Elsayed M, Solomon SB, Erinjeri JP, Schwartz LH, Sofocleous CT. Zirakchian Zadeh M, et al. Among authors: erinjeri jp. J Vasc Interv Radiol. 2024 Apr;35(4):523-532.e1. doi: 10.1016/j.jvir.2024.01.001. Epub 2024 Jan 10. J Vasc Interv Radiol. 2024. PMID: 38215818
Safety and Efficacy of Hepatic Artery Embolization in Heavily Treated Patients with Intrahepatic Cholangiocarcinoma: Analysis of Clinicopathological and Radiographic Parameters Associated with Better Overall Survival.
Velayati S, Elsakka A, Zhao K, Erinjeri JP, Marinelli B, Soliman M, Chevallier O, Ziv E, Brody LA, Sofocleous CT, Solomon SB, Harding JJ, Abou-Alfa GK, D'Angelica MI, Wei AC, Kingham PT, Jarnagin WR, Yarmohammadi H. Velayati S, et al. Among authors: erinjeri jp. Curr Oncol. 2023 Oct 18;30(10):9181-9191. doi: 10.3390/curroncol30100663. Curr Oncol. 2023. PMID: 37887563 Free PMC article.
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma.
Cowzer D, White JB, Chou JF, Chen PJ, Kim TH, Khalil DN, El Dika IH, Columna K, Yaqubie A, Light JS, Shia J, Yarmohammadi H, Erinjeri JP, Wei AC, Jarnagin W, Do RKG, Solit DB, Capanu M, Shah RH, Berger MF, Abou-Alfa GK, Harding JJ. Cowzer D, et al. JCO Precis Oncol. 2023 Sep;7:e2300272. doi: 10.1200/PO.23.00272. JCO Precis Oncol. 2023. PMID: 37769223
A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma.
Kelly CM, Qin LX, Whiting KA, Richards AL, Avutu V, Chan JE, Chi P, Dickson MA, Gounder MM, Keohan ML, Movva S, Nacev BA, Rosenbaum E, Adamson T, Singer S, Bartlett EK, Crago AM, Yoon SS, Hwang S, Erinjeri JP, Antonescu CR, Tap WD, D'Angelo SP. Kelly CM, et al. Among authors: erinjeri jp. Clin Cancer Res. 2023 Jun 1;29(11):2043-2051. doi: 10.1158/1078-0432.CCR-22-3911. Clin Cancer Res. 2023. PMID: 36971773 Free PMC article. Clinical Trial.
119 results